HOME > Investors > Press Releases
2017-10-12
ViroMed, VM202 Phase III for CLI Approved in China
2017-09-25
ViroMed, Gene Therapy Powerhouse on Global Stage
2017-09-22
VM202-ALS update release on ALS News Today
2017-09-12
DPhil. Sunyoung Kim, CSO of ViroMed, "Our gene therapy research is sailing through, and we are preparing for commercial production."
2017-08-25
Strides Toward New Approaches: Dawn of a New Era in DFU Treatment
1 2 3 4 5 6 7 8 9 10